المؤلفون: Mariama T. Brown, Sungchan Oh, Katy M. Rainey, Darcy E. P. Telenko

المصدر: PhytoFrontiers, Vol 4, Iss 4, Pp 544-552 (2024)

مصطلحات موضوعية: nondestructive, phenotyping, previsual, spectral reflectance, sudden death syndrome (SDS), Plant culture, SB1-1110, Botany, QK1-989

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2690-5442

URL الوصول: https://doaj.org/article/fe946e5439cd44cf8225f7573d0d71ca

المؤلفون: R. F. Nasyrova, A. V. Kidyaeva, M. M. Petrova, N. A. Shnayder, Р. Ф. Насырова, А. В. Кидяева, М. М. Петрова, Н. А. Шнайдер

المساهمون: The study was performed without external funding., Работа выполнена без спонсорской поддержки

المصدر: Safety and Risk of Pharmacotherapy; 2024: Online First ; Безопасность и риск фармакотерапии; 2024: Online First ; 2619-1164 ; 2312-7821 ; undefined

مصطلحات موضوعية: лечение, drug safety, adverse drug reactions, long QT syndrome, antipsychotic-induced QT prolongation, Torsade de Pointes, sudden death syndrome, mental disorder, treatment, безопасность лекарственных средств, нежелательные реакции, синдром удлинения QT, антипсихотик-индуцированное удлинение QT, Тorsade de Рointes, синдром внезапной смерти, психическое расстройство

وصف الملف: application/pdf

Relation: https://www.risksafety.ru/jour/article/view/410/1062; https://www.risksafety.ru/jour/article/view/410/1073; https://www.risksafety.ru/jour/article/view/410/1075; https://www.risksafety.ru/jour/article/view/410/1077; https://www.risksafety.ru/jour/article/view/410/1078; https://www.risksafety.ru/jour/article/view/410/1079; https://www.risksafety.ru/jour/article/view/410/1080; https://www.risksafety.ru/jour/article/view/410/1093; https://www.risksafety.ru/jour/article/view/410/1098; https://www.risksafety.ru/jour/article/view/410/1100; https://www.risksafety.ru/jour/article/view/410/1105; https://www.risksafety.ru/jour/article/view/410/1115; https://www.risksafety.ru/jour/article/downloadSuppFile/410/476; https://www.risksafety.ru/jour/article/downloadSuppFile/410/491; https://www.risksafety.ru/jour/article/downloadSuppFile/410/492; https://www.risksafety.ru/jour/article/downloadSuppFile/410/493; https://www.risksafety.ru/jour/article/downloadSuppFile/410/519; Chohan PS, Mittal R, Javed A. Antipsychotic medication and QT prolongation. Pak J Med Sci. 2015;31(5):1269–71. https://doi.org/10.12669/pjms.315.8998; Khasanova AK. Pharmacogenetic factors of clozapine-induced metabolic syndrome. Personalized Psychiatry and Neurology. 2023;3(2):38–47. https://doi.org/10.52667/2712-9179-2023-3-2-38-47; Giardin F, Gex-Fabry M, Berney P, Shah D, Gaspoz J, Dayer P. Drug-induced long QT in adult psychiatric inpatients: the 5-year cross-sectional ECG screening outcome in psychiatry study. Am J Psychiatry. 2013;170(12):1468–76. https://doi.org/10.1176/appi.ajp.2013.12060860; Акимова ЕС, Зиганшина ЛЕ, Лоранская ИД, Качан ВО, Клепикова МВ, Кочетков АИ и др. Лекарственно-индуцированные заболевания. М.: Прометей; 2022. EDN: SSCIYA; Lambiase PD, de Bono JP, Schilling RJ, Lowe M, Turley A, Slade A, et al. British Heart Rhythm Society Clinical practice guidelines on the management of patients developing QT prolongation on antipsychotic medication. Arrhythm Electrophysiol Rev. 2019;8(3):161–5. https://doi.org/10.15420/aer.2019.8.3.G1; Абриталин ЕЮ, Александровский ЮА, Ананьева НИ, Аничков АД, Ахапкин РВ, Букреева НД и др. Психиатрия: национальное руководство. М.: ГЭОТАР-Медиа; 2018. EDN: YMILDU; Gorobets LN, Semenova ND, Litvinov AV. Application of antipsychotic medication: gender differences in tolerance and medication response. Personalized Psychiatry and Neurology. 2022;2(2):57–66. https://doi.org/10.52667/2712-9179-2022-2-2-57-66; Zhou J, Zhu T, Zhu X, Galling B, Xiao L. Factors associated with antipsychotic use in non-psychotic depressed patients: results from a clinical multicenter survey. BMC Psychiatry. 2022;22(1):80. https://doi.org/10.1186/s12888-021-03411-y; Jha MK, Mathew SJ. Pharmacotherapies for treatment-resistant depression: how antipsychotics fit in the rapidly evolving therapeutic landscape. Am J Psychiatry. 2023;180(3):190–9. https://doi.org/10.1176/appi.ajp.20230025; Roessner V, Eichele H, Stern JS, Skov L, Rizzo R, Debes NM, et al. European clinical guidelines for Tourette syndrome and other tic disorders—version 2.0. Part III: pharmacological treatment. Eur Child Adolesc Psychiatry. 2022;31(3):425–41. https://doi.org/10.1007/s00787-021-01899-z; Leichsenring F, Heim N, Leweke F, Spitzer C, Steinert C, Kernberg OF. Borderline personality disorder: a review. JAMA. 2023;329(8):670–9. https://doi.org/10.1001/jama.2023.0589; Pascual JC, Arias L, Soler J. Pharmacological management of borderline personality disorder and common comorbidities. CNS Drugs. 2023;37:489–97. https://doi.org/10.1007/s40263-023-01015-6; Gomes T, Khuu W, Tadrous M, Vigod S, Cobigo V, Lunsky Y. Antipsychotic initiation among adults with intellectual and developmental disabilities in Ontario: a population-based cohort study. BMJ Open. 2019;9(7):e028125. https://doi.org/10.1136/bmjopen-2018-028125; Pompili M, Ducci G, Galluzzo A, Rosso G, Palumbo C, De Berardis D. The management of psychomotor agitation associated with schizophrenia or bipolar disorder: a brief review. Int J Environ Res Public Health. 2021;18(8):4368. https://doi.org/10.3390/ijerph18084368; Zareifopoulos N, Panayiotakopoulos G. Treatment options for acute agitation in psychiatric patients: theoretical and empirical evidence. Cureus. 2019;11(11):e6152. https://doi.org/10.7759/cureus.6152; Orzelska-Górka J, Mikulska J, Wiszniewska A, Biała G. New atypical antipsychotics in the treatment of schizophrenia and depression. Int J Mol Sci. 2022;23(18):10624. https://doi.org/10.3390/ijms231810624; MacKenzie NE, Kowalchuk C, Agarwal SM, Costa-Dookhan KA, Caravaggio F, Gerretsen P, et al. Antipsychotics, metabolic adverse effects, and cognitive function in schizophrenia. Front Psychiatry. 2018;9:622. https://doi.org/10.3389/fpsyt.2018.00622; Wunderink L. Personalizing antipsychotic treatment: evidence and thoughts on individualized tailoring of antipsychotic dosage in the treatment of psychotic disorders. Ther Adv Psychopharmacol. 2019;9:2045125319836566. https://doi.org/10.1177/2045125319836566; Остроумова ОД, Голобородова ИВ. Лекарственно-индуцированное удлинение интервала QT: распространенность, факторы риска, лечение и профилактика. Consilium Medicum. 2019;21(5):62–7. https://doi.org/10.26442/20751753.2019.5.190415; Волков ВП. Кардиотоксичность антипсихотических препаратов. Тверь: Триада; 2018. EDN: YMHBSX; Волков ВП. Нейролептическая кардиомиопатия. Тверь: Триада; 2020. EDN: TKMHCF; Friedrich ME, Winkler D, Konstantinidis A, Huf W, Engel R, Toto S, et al. Cardiovascular adverse reactions during antipsychotic treatment: results of AMSP, a drug surveillance program between 1993 and 2013. Int J Neuropsychopharmacol. 2020;23(2):67–75. https://doi.org/10.1093/ijnp/pyz046; Shnayder NA, Kidyaeva AV, Vaiman EE, Asadullin AR, Petrova MM, Kaskaeva DS, et al. Role of pharmacokinetics and pharmacogenetics of antidepressant-induced prolongation of the QT interval and Torsade de Pointes in patients with mental disorders. Personalized Psychiatry and Neurology. 2023;3(2):72–119. https://doi.org/10.52667/2712-9179-2023-3-2-72-119; Vandenberk B, Vandael E, Robyns T, Vandenberghe J, Garweg C, Foulon V, et al. Which QT correction formulae to use for QT monitoring? J Am Heart Assoc. 2016;5(6):e003264. https://doi.org/10.1161/JAHA.116.003264; Drew BJ, Ackerman MJ, Funk M, Gibler WB, Kligfield P, Menon V, et al. Prevention of Torsade de Pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. Circulation. 2010;121(8):1047–60. https://doi.org/10.1161/CIRCULATIONAHA.109.192704; Khatib R, Sabir FRN, Omari C, Pepper C, Tayebjee MH. Managing drug-induced QT prolongation in clinical practice. Postgrad Med J. 2021;97(1149):452–8. https://doi.org/10.1136/postgradmedj-2020-138661; Rochester MP, Kane AM, Linnebur SA, Fixen DR. Evaluating the risk of QTc prolongation associated with antidepressant use in older adults: a review of the evidence. Ther Adv Drug Saf. 2018;9(6):297–308. https://doi.org/10.1177/2042098618772979; Salvati B, Miola A, Toffanin T, Pigato G, Pavan C, Favaro A, et al. Prevalence and risk factors for QTc prolongation in acute psychiatric hospitalization. Prim Care Companion CNS Disord. 2022;24(1):21m02915. https://doi.org/10.4088/PCC.21m02915; Christensen L, Turner JR, Peterson GM, Naunton M, Thomas J, Yee KC, Kosari S. Identification of risk of QT prolongation by pharmacists when conducting medication reviews in residential aged care settings: a missed opportunity? J Clin Med. 2019;8(11):1866. https://doi.org/10.3390/jcm8111866; Danielsson B, Collin J, Nyman A, Bergendal A, Borg N, State M, et al. Drug use and torsades de pointes cardiac arrhythmias in Sweden: a nationwide register-based cohort study. BMJ Open. 2020;10(3):e034560. https://doi.org/10.1136/bmjopen-2019-034560; Salem JE, Dureau P, Bachelot A, Germain M, Voiriot P, Lebourgeois B, et al. Association of oral contraceptives with drug-induced QT interval prolongation in healthy nonmenopausal women. JAMA Cardiol. 2018;3(9):877–82. https://doi.org/10.1001/jamacardio.2018.2251; Li M, Ramos LG. Drug-induced QT prolongation and Torsades de Pointes. P T. 2017;42(7):473–7. PMID: 28674475; Iribarren C, Round AD, Peng JA, Lu M, Zaroff JG, Holve TJ, et al. Validation of a population-based method to assess drug-induced alterations in the QT interval: a self-controlled crossover study. Pharmacoepidemiol Drug Saf. 2013;22(11):1222–32. https://doi.org/10.1002/pds.3479; Hanna MP, Adie SK, Ketcham SW, Deshmukh A, Gondi K, Abdul-Aziz AA, et al. Atypical antipsychotic safety in the CICU. Am J Cardiol. 2022;163:117–23. https://doi.org/10.1016/j.amjcard.2021.09.052; Mizuki Y, Takaki M. Blonanserin ameliorated the tendency toward QTc prolongation associated with risperidone in a patient with schizophrenia. J Clin Psychopharmacol. 2015;35(1):101–2. https://doi.org/10.1097/JCP.0000000000000267; Kambayashi R, Hagiwara-Nagasawa M, Goto A, Chiba K, Izumi-Nakaseko H, Naito AT, et al. Experimental analysis of the onset mechanism of TdP reported in an LQT3 patient during pharmacological treatment with serotonin-dopamine antagonists against insomnia and nocturnal delirium. Heart Vessels. 2020;35(4):593–602. https://doi.org/10.1007/s00380-019-01521-y; Xiang YT, Chiu HF, Ungvari GS, Correll CU, Lai KY, Wang CY, et al. QTc prolongation in schizophrenia patients in Asia: clinical correlates and trends between 2004 and 2008/2009. Hum Psychopharmacol. 2015;30(2):94–9. https://doi.org/10.1002/hup.2458; Berling I, Isbister GK. Prolonged QT risk assessment in antipsychotic overdose using the QT nomogram. Ann Emerg Med. 2015;66(2):154–64. https://doi.org/10.1016/j.annemergmed.2014.12.005; Raschi E, Poluzzi E, Salvo F, Koci A, Suling M, Antoniazzi S, et al. The contribution of national spontaneous reporting systems to detect signals of torsadogenicity: issues emerging from the ARITMO project. Drug Saf. 2016;39(1):59–68. https://doi.org/10.1007/s40264-015-0353-1; Tariot PN, Cummings JL, Soto-Martin ME, Ballard C, Erten-Lyons D, Sultzer DL, et al. Trial of pimavanserin in dementia-related psychosis. N Engl J Med. 2021;385(4):309–19. https://doi.org/10.1056/NEJMoa2034634; Nielsen J, Wang F, Graff C, Kanters JK. QT dynamics during treatment with sertindole. Ther Adv Psychopharmacol. 2015;5(1):26–31. https://doi.org/10.1177/2045125314560738; Campleman SL, Brent J, Pizon AF, Shulman J, Wax P, Manini AF; Toxicology Investigators’ Consortium (ToxIC). Drug-specific risk of severe QT prolongation following acute drug overdose. Clin Toxicol (Phila). 2020;58(12):1326–34. https://doi.org/10.1080/15563650.2020.1746330; Pereira L, Budovich A, Claudio-Saez M. Monitoring of metabolic adverse effects associated with atypical antipsychotic use in an outpatient psychiatric clinic. J Pharm Pract. 2018;32:1–6. https://doi.org/10.1177/0897190017752712; Sicouri S, Antzelevitch C. Mechanisms underlying the actions of antidepressant and antipsychotic drugs that cause sudden cardiac arrest. Arrhythm Electrophysiol Rev. 2018;7(3):199–209. https://doi.org/10.15420/aer.2018.29.2; Bordet C, Garcia P, Salvo F, Touafchia A, Galinier M, Sommet A, Montastruc F. Antipsychotics and risk of QT prolongation: a pharmacovigilance study. Psychopharmacology (Berl). 2023;240(1):199–202. https://doi.org/10.1007/s00213-022-06293-4; Yap YG, Camm AJ. Drug induced QT prolongation and Torsades de Pointes. Heart. 2003;89(11):1363–72. https://doi.org/10.1136/heart.89.11.1363; Hasnain M, Vieweg WV, Howland RH, Kogut C, Breden Crouse EL, Koneru JN, et al. Quetiapine and the need for a thorough QT/QTc study. J Clin Psychopharmacol. 2014;34(1):3–6. https://doi.org/10.1097/JCP.0000000000000075; Duncan RS, McPate MJ, Ridley JM, Gao Z, James AF, Leishman DJ, et al. Inhibition of the HERG potassium channel by the tricyclic antidepressant doxepin. Biochem Pharmacol. 2007;74(3):425–37. https://doi.org/10.1016/j.bcp.2007.04.024; Naksuk N, Thongprayoon C, Park JY, Sharma S, Gaba P, Rosenbaum AN, et al. Editor’s choice-clinical impact of delirium and antipsychotic therapy: 10-year experience from a referral coronary care unit. Eur Heart J Acute Cardiovasc Care. 2017;6(6):560–8. https://doi.org/10.1177/2048872615592232; Beach SR, Celano CM, Sugrue AM, Adams C, Ackerman MJ, Noseworthy PA, Huffman JC. QT prolongation, Torsades de Pointes, and psychotropic medications: a five year update. Psychosomatics. 2018;59(2):105–22. https://doi.org/10.1016/j.psym.2017.10.009; Schmidt A, Fischer P, Wally B, Scharfetter J. Influence of intravenous administration of the antipsychotic drug benperidol on the QT interval. Neuropsychiatr. 2017;31(4):172–5. https://doi.org/10.1007/s40211-017-0230-5; Zhu MH, Liu ZJ, Hu QY, Yang JY, Jin Y, Zhu N, et al. Amisulpride augmentation therapy improves cognitive performance and psychopathology in clozapine-resistant treatment-refractory schizophrenia: a 12-week randomized, double-blind, placebo-controlled trial. Mil Med Res. 2022;9(1):59. https://doi.org/10.1186/s40779-022-00420-0; Aronow WS, Shamliyan TA. Effects of atypical antipsychotic drugs on QT interval in patients with mental disorders. Ann Transl Med. 2018;6(8):147. https://doi.org/10.21037/atm.2018.03.17; Zhuravlev NM, Shnayder NA, Vaiman EE, Abdyrakhmanova AK, Petrova MM, Bochanova EN, et al. Interindividual variability of anticonvulsant-induced QT prolongation risk. Personalized Psychiatry and Neurology. 2022;1(2):22–45. https://doi.org/10.52667/2712-9179-2022-2-1-23-45; Iwata N, Ishigooka J, Naoi I, Matsumoto M, Kanamori Y, Nakamura H, Higuchi T. Long-term safety and efficacy of blonanserin transdermal patches in Japanese patients with schizophrenia: a 52-week open-label, multicenter study. CNS Drugs. 2020;34(1):103–16. https://doi.org/10.1007/s40263-019-00692-6; Kane JM, Peters-Strickland T, Baker RA, Hertel P, Eramo A, Jin N, et al. Aripiprazole once-monthly in the acute treatment of schizophrenia: findings from a 12-week, randomized, double-blind, placebo-controlled study. J Clin Psychiatry. 2014;75(11):1254–60. https://doi.org/10.4088/JCP.14m09168; Nasrallah HA, Aquila R, Du Y, Stanford AD, Claxton A, Weiden PJ. Long-term safety and tolerability of aripiprazole lauroxil in patients with schizophrenia. CNS Spectr. 2019;24(4):395–403. https://doi.org/10.1017/S1092852918001104; Pigott TA, Carson WH, Saha AR, Torbeyns AF, Stock EG, Ingenito GG; Aripiprazole Study Group. Aripiprazole for the prevention of relapse in stabilized patients with chronic schizophrenia: a placebo-controlled 26-week study. J Clin Psychiatry. 2003;64(9):1048–56. https://doi.org/10.4088/jcp.v64n0910; Kasper S, Lerman MN, McQuade RD, Saha A, Carson WH, Ali M, et al. Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia. Int J Neuropsychopharmacol. 2003;6(4):325–37. https://doi.org/10.1017/S1461145703003651; Bugarski-Kirola D, Bitter I, Liu IY, Abbs B, Stankovic S. ENHANCE: phase 3, randomized, double-blind, placebo-controlled study of adjunctive pimavanserin for schizophrenia in patients with an inadequate response to antipsychotic treatment. Schizophr Bull Open. 2022;3:sgac006. https://doi.org/10.1093/schizbullopen/sgac006; Bugarski-Kirola D, Arango C, Fava M, Nasrallah H, Liu IY, Abbs B, Stankovic S. Pimavanserin for negative symptoms of schizophrenia: results from the ADVANCE phase 2 randomised, placebo-controlled trial in North America and Europe. Lancet Psychiatry. 2022;9(1):46–58. https://doi.org/10.1016/S2215-0366(21)00386-2; Ozeki Y, Fujii K, Kurimoto N, Yamada N, Okawa M, Aoki T, et al. QTc prolongation and antipsy chotic medications in a sample of 1017 patients with schizo phrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34(2):401–5. https://doi.org/10.1016/j.pnpbp.2010.01.008; Beach SR, Gross AF, Hartney KE, Taylor JB, Rundell JR. Intravenous haloperidol: a systematic review of side effects and recommendations for clinical use. Gen Hosp Psychiatry. 2020;67:42–50. https://doi.org/10.1016/j.genhosppsych.2020.08.008; Малин ДИ, Рывкин ПВ, Булатова ДР. Синдром удлиненного интервала QT при применении антипсихотических и антидепрессивных препаратов. Современная терапия психических расстройств. 2023;(2):48–56. https://doi.org/10.21265/PSYPH.2023.69.57.006; Hommers L, Scherf-Clavel M, Stempel R, Roth J, Falter M, Deckert J, et al. Antipsychotics in routine treatment are minor contributors to QT prolongation compared to genetics and age. J Psychopharmacol. 2021;35(9):1127–33. https://doi.org/10.1177/02698811211003477; Preda A, Shapiro BB. A safety evaluation of aripiprazole in the treatment of schizophrenia. Expert Opin Drug Saf. 2020;19(12):1529–38. https://doi.org/10.1080/14740338.2020.1832990; Beach SR, Celano CM, Noseworthy PA, Januzzi JL, Huffman JC. QTc prolongation, torsades de pointes, and psychotropic medications. Psychosomatics. 2013;54(1):1–13. https://doi.org/10.1016/j.psym.2012.11.001; Wu CS, Tsai YT, Tsai HJ. Antipsychotic drugs and the risk of ventricular arrhythmia and/or sudden cardiac death: a nation-wide case-crossover study. J Am Heart Assoc. 2015;4(2):e001568. https://doi.org/10.1161/JAHA.114.001568; Leucht S, Cipriani A, Spineli L, et al. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet. 2015;3:925–927. https://doi.org/10.1016/S0140-6736(13)60733-3; Carrà G, Crocamo C, Bartoli F, Lax A, Tremolada M, Lucii C, et al. First-generation antipsychotics and QTc: any role for mediating variables? Hum Psycho pharmacol. 2016;31(4):313–8. https://doi.org/10.1002/hup.2540; Silvestre JS, Prous JR. Comparative evaluation of hERG potassium channel blockade by antipsychotics. Methods Find Exp Clin Pharmacol. 2007;29(7):457–65. https://doi.org/10.1358/mf.2007.29.7.1119172; Lehmann DF, Eggleston WD, Wang D. Validation and clinical utility of the hERG IC 50 :C max ratio to determine the risk of drug-induced Torsades de Pointes: a meta-analysis. Pharmacotherapy. 2018;38(3):341–8. https://doi.org/10.1002/phar.2087; Tie H, Walker BD, Valenzuela SM, Breit SN, Campbell TJ. The heart of psychotropic drug therapy. Lancet. 2000;355(9217):1825. https://doi.org/10.1016/S0140-6736(05)73083-X; Le Marois M, Sanson C, Maizières MA, Partiseti M, Bohme GA. The atypic antipsychotic clozapine inhibits multiple cardiac ion channels. Naunyn Schmiedebergs Arch Pharmacol. 2023;396(1):161–6. https://doi.org/10.1007/s00210-022-02314-3; Lee HJ, Choi JS, Hahn SJ. Mechanism of inhibition by olanzapine of cloned hERG potassium channels. Neurosci Lett. 2015;609:97–102. https://doi.org/10.1016/j.neulet.2015.10.039; Lee HJ, Choi BH, Choi JS, Hahn SJ. Effects of iloperidone on hERG 1A/3.1 heterotetrameric channels. Neuroreport. 2021;32(16):1299–306. https://doi.org/10.1097/WNR.0000000000001724; Lee HJ, Choi JS, Choi BH, Hahn SJ. Inhibition of cloned hERG potassium channels by risperidone and paliperidone. Naunyn Schmiedebergs Arch Pharmacol. 2017;390(6):633–42. https://doi.org/10.1007/s00210-017-1364-5; Tamargo J. Drug-induced Torsade de Pointes: from molecular biology to bedside. Jpn J Pharmacol. 2000;83:1–19. https://doi.org/10.1254/jjp.83.1; https://www.risksafety.ru/jour/article/view/410

الاتاحة: https://www.risksafety.ru/jour/article/view/410
https://doi.org/10.30895/2312-7821-2024-410

المؤلفون: Zeina Boroumandnia, Heshmatollah Khosravinia, Babak Masouri, Bahman Parizadian Kavan

المصدر: Poultry Science Journal, Vol 9, Iss 2, Pp 197-206 (2021)

مصطلحات موضوعية: vitamin d3, lactic acidosis, broiler chicken, sudden death syndrome, Animal culture, SF1-1100

وصف الملف: electronic resource

Relation: https://psj.gau.ac.ir/article_5859_b4b0afac41ea1fddefad137d27209c85.pdf; https://doaj.org/toc/2345-6604; https://doaj.org/toc/2345-6566

URL الوصول: https://doaj.org/article/a0cbf46b49c2481bae4a6784e4cd721f

المؤلفون: N. M. Zhuravlev, N. A. Shnayder, R. F. Nasyrova, Н. М. Журавлёв, Н. А. Шнайдер, Р. Ф. Насырова

المصدر: Pharmacogenetics and Pharmacogenomics; № 1 (2022); 37-52 ; Фармакогенетика и фармакогеномика; № 1 (2022); 37-52 ; 2588-0527 ; 2686-8849

مصطلحات موضوعية: желудочковая тахиаритмия, antiepileptic drug, cardiac repolarization, QT interval, drug-induced long QT syndrome, sudden death syndrome, ventricular tachyarrhythmia, противоэпилептический препарат, реполяризация желудочков сердца, интервал QT, лекарственно- индуцированный синдром удлинённого интервала QT, синдром внезапной смерти

وصف الملف: application/pdf

Relation: https://www.pharmacogenetics-pharmacogenomics.ru/jour/article/view/244/236; Карлов В. А. Эпилепсия у детей и взрослых мужчин и женщин. М.: БИНОМ-Пресс, 2019. 896 с. [Karlov VA. Epilepsiya u detej i vzroslyh muzhchin i zhenshchin. Moscow: BINOM-Press, 2019. (In Russ).].; Шнайдер Н. А., Петрова М. М., Петров К. В., Насырова Р. Ф. Фармакологические предикторы нарушения сердечного ритма и проводимости при юношеской миоклонической эпилепсии. Эпилепсия и пароксизмальные состояния. 2021;13(2):168–79. [Shnayder NA, Petrova MM, Petrov KV, Nasyrova RF. Pharmacological predictors of heart rate and conductivity disorders in juvenile myoclonic epilepsy. Epilepsiya i paroksizmalʹnye sostoyania = Epilepsy and Paroxysmal Conditions. 2021;13(2):168–179. (In Russ).]. DOI:10.17749/2077-8333/epi.par.con.2021.051; Бородулина И. В., Рачин А. П. Полинейропатии в практике врача: особенности патогенеза, клиники и современные подходы к лечению болевых и безболевых форм. РМЖ. 2016;25:1705–1710. [Borodulina IV, Rachin AP. Polyneuropathies: pathogenesis, clinical manifestations, and current treatment approaches to painful and painless conditions. RMJ. 2016;25:1705–1710. (In Russ).].; Auerbach DS, Biton Y, Polonsky B, McNitt S, Gross RA, Dirksen RT, Moss AJ. Risk of cardiac events in Long QT syndrome patients when taking antiseizure medications. Transl Res. 2018 Jan;191:81–92.e7. DOI:10.1016/j.trsl.2017.10.002; Talaeı A, Farıdhosseını F, Kazemı H, Fayyazı Bordbar MR, Rezaeı Ardanı A. Topiramatın Şizofreni ve İki Uçlu Duygudurum I Bozukluğu Olan Hastalarda İlaca Bağlı Kilo Alımına Etkileri: Doz Ayarlarının Seçkisiz Klinik Çalışması. [Effect of Topiramate on Drug Associated Weight Gain of Patients with Schizophrenia and Bipolar I Disorders: A Dose Ranging Randomized Trial]. Turk Psikiyatri Derg. 2016 Summer;27(2):0. Turkish. PMID: 27370059.; Демьянов И. А., Сурикова В. В., Мельник Е. Ю. Современные тенденции использования антиконвульсантов в психиатрической практике. Вестник СПбГУ. Медицина. 2017;12(3):235–242. [Current trends in the use of anticonvulsants in psychiatric practice. Vestnik SPbSU. Medicine. 2017;12(3):235–242. (In Russ).]. DOI:10.21638/11701/spbu11.2017.303; Brunetti P, Giorgetti R, Tagliabracci A, Huestis MA, Busardò FP. Designer Benzodiazepines: A Review of Toxicology and Public Health Risks. Pharmaceuticals (Basel). 2021 Jun 11;14(6):560. DOI:10.3390/ph14060560; Федеральный закон от 12.04.2010 № 61-ФЗ (ред. от 11.06.2021) «Об обращении лекарственных средств». [Federal Law No. 61-FZ “Ob obrashchenii lekarstvennyh sredstv” dated 12.04.2010 (as amended on 11.06.2021). (In Russ).].; Приказ Росздравнадзора от 15.02.2017 № 1071 (ред. от 16.07.2020) «Об утверждении Порядка осуществления фармаконадзора». [Order of Roszdravnadzor No. 1071 “Ob utverzhdenii Poryadka osushchestvleniya farmakonadzora” dated 15.02.2017 (as amended on 16.07.2020) (In Russ).].; Бочанова Е. Н., Шнайдер Н. А., Дмитренко Д. В. и др. Опыт регистрации нежелательных побочных реакций на противоэпилептические препараты в клинике Красноярского медицинского университета. Врач. 2016;4:6–8. [Bochanova EN, Shnayder NA, Dmitrenko DV, et al. Experience in recording undesirable side effects from antiepileptic drugs in the Krasnoyarsk medical university clinic. VRACH. 2016;4:6–8. (In Russ).].; Zhuravlev NM, Shnayder NA, Vaiman EE, Abdyrakhmanova AK, Petrova MM, Bochanova EN, Romanova IV, Gavrilyuk OA, Lareva NV, Nasyrova RF. Interindividual Variability of Anticonvulsant-Induced QT Prolongation Risk. Personalized Psychiatry and Neurology. 2022;2(1):22–45. DOI:10.52667/2712-9179-2022-2-1-23-45; Приказ Минздрава России от 01.02.2019 № 42 (ред. от 24.08.2020) «Об утверждении ведомственной целевой программы “Развитие фундаментальной, трансляционной и персонализированной медицины”». [Order of the Ministry of Health of Russia No. 42 “On approval of the departmental target program “Development of fundamental, translational and personalized medicine” dated 01.02.2019 (as amended on 24.08.2020). (In Russ).].; Салмина А. Б., Шнайдер Н. А., Михуткина С. В. Современные представления об ионных каналах и каналопатиях (обзор литературы). Сибирское медицинское обозрение.2005;34(1):75–78. [Salmina AB, Shnayder NA, Mikhutkina SV. Sovremennye predstavleniya ob ionnyh kanalah i kanalopatiyah (obzor literatury). Siberian Medical Review. 2005;34(1):75–78. (In Russ).].; Neira V, Enriquez A, Simpson C, Baranchuk A. Update on long QT syndrome. J Cardiovasc Electrophysiol. 2019 Dec;30(12):3068–3078. DOI:10.1111/jce.14227; Nakano Y, Shimizu W. Genetics of long-QT syndrome. J Hum Genet. 2016;61(1):51–55. DOI:10.1038/jhg.2015.74; Alders M, Bikker H, Christiaans I. Long QT Syndrome. 2003 Feb 20 [updated 2018 Feb 8]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mirzaa G, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2021. PMID: 20301308.; Goldenberg I, Zareba W, Moss AJ. Long QT Syndrome. Curr Probl Cardiol. 2008;33(11):629–694. DOI:10.1016/j.cpcardiol.2008.07.002; Schwartz PJ, Crotti L, Insolia R. Long-QT syndrome: from genetics to management. Circ Arrhythm Electrophysiol. 2012;5(4):868–877. DOI:10.1161/CIRCEP.111.962019. Erratum in: Circ Arrhythm Electrophysiol. 2012 Dec;5(6):e119–20. PMID: 22895603.; Zareba W, Moss AJ, Schwartz PJ, et al. Influence of the genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. N Engl J Med. 1998;339(14):960–965. DOI:10.1056/NEJM199810013391404; Nannenberg EA, Sijbrands EJ, Dijksman LM, et al. Mortality of inherited arrhythmia syndromes: insight into their natural history. Circ Cardiovasc Genet. 2012;5(2):183–189. DOI:10.1161/CIRCGENETICS.111.961102; Goldenberg I, Horr S, Moss AJ, et al. Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normalrange corrected QT intervals. J Am Coll Cardiol. 2011;57(1):51–59. DOI:10.1016/j.jacc.2010.07.038; Lankaputhra M, Voskoboinik A. Congenital Long QT Syndrome: A Clinician’s Guide. Internal Medicine Journal. 2021;51(12):1999–2011. DOI:10.1111/imj.15437; Committee For Proprietary Medicinal Products (CPMP) Points to consider: The assessment of the potential for QT interval prolongation by non-cardiovascular medicinal products. London: 1997 Dec.; Jervell A, Lange-Nielsen F. Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval and sudden death. Am Heart J. 1957;54(1):59–68. DOI:10.1016/0002-8703(57)90079-0; Horner JM, Horner MM, Ackerman MJ. The diagnostic utility of recovery phase QTc during treadmill exercise stress testing in the evaluation of long QT syndrome. Heart Rhythm. 2011;8(11):1698–1704. DOI:10.1016/j.hrthm.2011.05.018; Sy RW, van der Werf C, Chattha IS, et al. Derivation and validation of a simple exercise-based algorithm for prediction of genetic testing in relatives of LQTS probands. Circulation. 2011;124(20):2187–2194. DOI:10.1161/CIRCULATIONAHA.111.028258; Zhang L, Timothy KW, Vincent GM, et al. Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes. Circulation. 2000;102(23):2849–2855. DOI:10.1161/01.cir.102.23.2849; Viskin S, Postema PG, Bhuiyan ZA, et al. The response of the QT interval to the brief tachycardia provoked by standing: a bedside test for diagnosing long QT syndrome. J Am Coll Cardiol. 2010;55(18):1955–1961. DOI:10.1016/j.jacc.2009.12.015; Ackerman MJ, Khositseth A, Tester DJ, et al. Epinephrine-induced QT interval prolongation: a gene-specific paradoxical response in congenital long QT syndrome. Mayo Clin Proc. 2002;77(5):413–421. DOI:10.4065/77.5.413; Shimizu W, Noda T, Takaki H, et al. Diagnostic value of epinephrine test for genotyping LQT1, LQT2, and LQT3 forms of congenital long QT syndrome. Heart Rhythm. 2004;1(3):276–283. DOI:10.1016/j.hrthm.2004.04.021; Vyas H, Hejlik J, Ackerman MJ. Epinephrine QT stress testing in the evaluation of congenital long-QT syndrome: diagnostic accuracy of the paradoxical QT response. Circulation. 2006;113(11):1385–1392. DOI:10.1161/CIRCULATIONAHA.105.600445; Schwartz PJ, Moss AJ, Vincent GM, Crampton RS. Diagnostic criteria for the long QT syndrome. An update. Circulation. 1993;88(2):782–784. DOI:10.1161/01.cir.88.2.782; Schwartz PJ, Crotti L. QTc behavior during exercise and genetic testing for the long-QT syndrome. Circulation. 2011;124(20):2181–2184. DOI:10.1161/CIRCULATIONAHA.111.062182; Priori SG, Wilde AA, Horie M, et al. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm. 2013;10(12):1932–1963. DOI:10.1016/j.hrthm.2013.05.014; Castiglione A, Odening K. QT-Zeit — Was fange ich eigentlich damit an? [QT Interval and Its Prolongation — What Does It Mean?]. Dtsch Med Wochenschr. 2020 Apr;145(8):536–542. German. DOI:10.1055/a-0969-6312; Эпилепсия и спорт: руководство для врачей / под ред. Н. А. Шнайдер, М. М. Петровой, Р. Ф. Насыровой, О. В. Балберовой. СПб.: ДЕАН, 2022. 248 с. ISBN 978-5-6048707-0-9. [Epilepsy and sport: a guide for physicians. Ed by Shnayder NA, Petrova MM, Nasyrova RF, Balberova OV. Saint-Petersburg: DEAN; 2022. (In Russ).].; Parks KA, Parks CG, Yost JP, et al. Acute blood pressure changes associated with antipsychotic administration to psychiatric inpatients. Prim Care Companion CNS Disord. 2018;20(4):18m02299. DOI:10.4088/PCC.18m02299; Nagy D, DeMeersman R, Gallagher D, et al. QTc interval (cardiac repolarisation): Lengthening after meals. Obes Res. 1997;5:531–537. DOI:10.1002/j.1550-8528.1997.tb00573.x; Wenzel-Seifert K, Wittmann M, Haen E. QTc prolongation by psychotropic drugs and the risk of Torsade de Pointes. Dtsch Arztebl Int. 2011;108(41):687–693. DOI:10.3238/arztebl.2011.0687; Brown DW, Giles WH, Greenlund KJ et al. Impaired fasting glucose, diabetes mellitus, and cardiovascular disease risk factors are associated with prolonged QTc duration. Results from the Third National Health and Nutrition Examination Survey. J Cardiovasc Risk. 2001;8(4):227–233. DOI:10.1177/174182670100800407; van Noord C, Eijgelsheim M, Stricker BH. Drug- and non-drugassociated QT interval prolongation. Br J Clin Pharmacol. 2010;70(1):16–23. DOI:10.1111/j.1365-2125.2010.03660.x; Carella MJ, Mantz SL, Rovner DR, et al. Obesity, adiposity, and lengthening of the QT interval: improvement after loss. Int J Obes Relat Metab Disord. 1996;20(10):938–942. PMID: 8910099.; El-Gamal A, Gallagher D, Nawras A, et al. Effects of obesity on QT, RR, and QTc intervals. Am J Cardiol.1995:75(14):956–959. DOI:10.1016/s0002-9149(99)80700-0; Zareba W, Lin DA. Antipsychotic drugs and QT interval prolongation. Psychiatr Q. 2003;74(3):291–306. DOI:10.1023/a:102412270633745. Zipes DP, Wellens HJJ. Sudden cardiac death. Circulation. 1998;98:233451.; Shah AA, Aftab A, Coverdale J. QTc prolongation with antipsychotics: is routine ECG monitoring recommended? J Psychiatr Pract. 2014;20(3):196– 206. DOI:10.1097/01.pra.0000450319.21859.6d; Joukamaa M, Heliövaara M, Knekt P, et al. Schizophrenia, neuroleptic medication and mortality. Br J Psychiatry. 2006;188(2):122–127. DOI:10.1192/bjp.188.2.122; Escande D. Pharmacogenetics of cardiac K(+) channels. Eur J Pharmacol. 2000;410(2-3):281–287. DOI:10.1016/s0014-2999(00)00821-9; Varkey JN, Frishman WH. Arrhythmogenesis and COVID-19. Cardiol Rev. 2021;29(6):289–291. DOI:10.1097/CRD.0000000000000407; Vincent GM. The molecular genetics of the long QT syndrome: genes causing fainting and sudden death. Annu Rev Med. 1998;49:263–274. DOI:10.1146/annurev.med.49.1.263; Khera AV, Mason-Suares Н, Brockman D, et al. Rare Genetic Variants Associated With Sudden Cardiac Death in Adults. J Am Coll Cardiol. 2019;74(21):2623–2634. DOI:10.1016/j.jacc.2019.08.1060; Chen L, Zhang W, Fang C et al. Polymorphism H558R in the human cardiac sodium channel SCN5A gene is associated with atrial fibrillation. J Int Med Res. 2011;39(5):1908–1916. DOI:10.1177/147323001103900535; Spellmann I, Reinhard MA, Veverka D, et al. QTc prolongation in short-term treatment of schizophrenia patients: effects of different antipsychotics and genetic factors. Eur Arch Psychiatry Clin Neurosci. 2018;268(4):383–390. DOI:10.1007/s00406-018-0880-8; Gouas L, Nicaud V, Berthet M et al. Association of KCNQ1, KCNE1, KCNH2 and SCN5A polymorphisms with QTc interval length in a healthy population. Eur J Hum Genet. 2005;13(11):1213–1222. DOI:10.1038/sj.ejhg.5201489; Hobday P, Mahoney D, Urban L, et al. Influence of the common H558R-SCN5A sodium channel polymorphism on the electrocardiographic phenotype in a population-based study. Heart Rhythm. 2005;3:S279–S280. DOI: doi.org/10.1016/j.hrthm.2006.02.837; Lehtinen AB, Daniel KR, Shah SA, et al. Relationship between genetic variants in myocardial sodium and potassium channel genes and QT interval duration in diabetics: the Diabetes Heart Study. Ann Noninvasive Electrocardiol. 2009;14(1):72–79. DOI:10.1111/j.1542-474X.2008.00276.x; Pfeufer A, Sanna S, Arking DE, et al. Common variants at ten loci modulate the QT interval duration in the QTSCD Study. Nat Genet. 2009;41(4):407–414. DOI:10.1038/ng.362; Chiang CE, Roden DM. The long QT syndromes: genetic basis and clinical implications. J Am Coll Cardiol. 2000;36(1):1–12. DOI:10.1016/s0735-1097(00)00716-6; Koskela J, Kähönen М, Fan М, et al. Effect of common KCNE1 and SCN5A ion channel gene variants on T-wave alternans, a marker of cardiac repolarization, during clinical exercise stress test: the Finnish Cardiovascular Study. Transl Res. 2008;152(2):49–58. DOI:10.1016/j.trsl.2008.06.003; Barhanin J, Lesage F, Guillemare E, et al. KvLQT1 and IsK (minK) proteins associate to form the IKS cardiac potassium current. Nature. 1996;384:78–80. DOI:10.1038/384078a0; Marx SO, Kurokawa J, Reiken S, Motoike H, D’Armiento J, Marks AR, Kass RS. Requirement of a macromolecular signaling complex for beta adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel. Science. 2002 Jan 18;295(5554):496–499. DOI:10.1126/science.1066843; De Villiers CP, van der Merwe L, Crotti L et al. AKAP9 is a genetic modifier of congenital long-QT syndrome type 1. Circ Cardiovasc Genet. 2014;7(5):599–606. DOI:10.1161/CIRCGENETICS.113.000580; Клиническая психофармакогенетика / под ред. Р. Ф. Насыровой, Н. Г. Незнанова.СПб.: ДЕАН, 2020. 408 с. [Clinical psychopharmacogenetics. Ed by Nasyrova RF, Neznanov NG. Saint-Petersburg: DEAN; 2020. (In Russ).].; Balestrini S, Sisodiya Sanjay M. Pharmacogenomics in epilepsy. Neuroscience Letters. 2021;29(6):289–291. DOI:10.1016/j.neulet.2017.01.014; Остроумова О. Д., Голобородова И. В. Влияние отдельных групп лекарственных препаратов на риск удлинения интервала QTс. Consilium Medicum. 2019;21(10):95–106. [Ostroumova OD, Goloborodova IV. The effect of individual groups of drugs on the risk of prolongation of the QTc interval. Consilium Medicum. 2019;21(10):95–106. (In Russ).]. DOI:10.26442/20751753.2019.10.190447; Neznanov NG. A paradigm shift to treat psychoneurological disorders. Personalized Psychiatry and Neurology. 2021;1(1):1–2.; Fanoe S, Kristensen D, Fink-Jensen A, et al. Risk of arrhythmia induced by psychotropic medications: a proposal for clinical management. Eur Heart J. 2014;35(20):1306–1315. DOI:10.1093/eurheartj/ehu100; https://www.pharmacogenetics-pharmacogenomics.ru/jour/article/view/244

الاتاحة: https://www.pharmacogenetics-pharmacogenomics.ru/jour/article/view/244
https://doi.org/10.37489/2588-0527-2022-1-37-52

المؤلفون: Leandro Lopes da Silva, Huan Tian, Brandi Schemerhorn, Jin-Rong Xu, Guohong Cai

المصدر: Journal of Fungi, Vol 9, Iss 11, p 1109 (2023)

مصطلحات موضوعية: soybean, sudden death syndrome, Fusarium virguliforme, microsatellite marker, population structure, Argentina, Biology (General), QH301-705.5

وصف الملف: electronic resource

Relation: https://www.mdpi.com/2309-608X/9/11/1109; https://doaj.org/toc/2309-608X

URL الوصول: https://doaj.org/article/30542bb6cd644c129753e557e3b6600b

المؤلفون: Zeinab Boroumandnia, Heshmatollah Khosravinia, Babak Masouri, Bahman Parizadian Kavan

المصدر: Italian Journal of Animal Science, Vol 20, Iss 1, Pp 153-162 (2021)

مصطلحات موضوعية: broiler chicken, lactic acidosis, sudden death syndrome, guanidinoacetic acid, Animal culture, SF1-1100

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1594-4077; https://doaj.org/toc/1828-051X

URL الوصول: https://doaj.org/article/2a083660962c4b0abd5fece3eaf1a506

المؤلفون: Abdelsamad, N. A.¹, Baumbach, J.², Bhattacharyya, M. K.², Leandro, L. F.¹ Ileandro@iastate.edu

المصدر: Plant Disease. May2017, Vol. 101 Issue 5, p712-719. 8p.

مصطلحات موضوعية: *SOYBEAN sudden death syndrome, *SOYBEAN diseases & pests, *FUSARIUM diseases of plants, *FUNGAL diseases of plants, *PECTATE lyase

المؤلفون: Elena E. Vaiman, Natalia A. Shnayder, Nikita M. Zhuravlev, Marina M. Petrova, Azat R. Asadullin, Mustafa Al-Zamil, Natalia P. Garganeeva, German A. Shipulin, Paul Cumming, Regina F. Nasyrova

المصدر: International Journal of Molecular Sciences; Volume 23; Issue 24; Pages: 15786

مصطلحات موضوعية: schizophrenia, antipsychotics, adverse drug reaction, antipsychotic-induced repolarization disorder, cardiac repolarization, long QT interval, sudden death syndrome, ventricular tachyarrhythmia, pharmacogenetics

جغرافية الموضوع: agris

وصف الملف: application/pdf

Relation: Molecular Neurobiology; https://dx.doi.org/10.3390/ijms232415786

الاتاحة: https://doi.org/10.3390/ijms232415786

المؤلفون: Giachero, María Lorena, Marquez, Nathalie, Ortega, Leandro Ismael, Ducasse, Daniel Adrian

المصدر: BioRxiv : the preprint server for biology. (March 7, 2022)

مصطلحات موضوعية: Lignins, Biopolymers, Cell Walls, Soybeans, Soja, Ligninas, Pared Celular, Biopolímeros, Sudden Death Syndrome, Suberin

وصف الملف: application/pdf

Relation: info:eu-repograntAgreement/INTA/PNPV-1135024/AR./Defensa en plantas contra fitopatógenos.; http://hdl.handle.net/20.500.12123/11405; https://www.biorxiv.org/content/10.1101/2022.03.07.483270v1.article-info; https://doi.org/10.1101/2022.03.07.483270

الاتاحة: https://hdl.handle.net/20.500.12123/11405
https://www.biorxiv.org/content/10.1101/2022.03.07.483270v1.article-info
https://doi.org/10.1101/2022.03.07.483270

المؤلفون: Kolstad, Erin¹

المصدر: Agri Marketing. Jan/Feb2021, Vol. 59 Issue 2, p19-22. 3p.

مصطلحات موضوعية: SEED treatment, SOYBEAN sudden death syndrome, SOYBEAN yield, SOYBEAN cyst nematode

الشركة/الكيان: SYNGENTA Crop Protection Inc. 966616633

المؤلفون: Tewoldemedhin, Yared T.¹ TewoldemedhinY@arc.agric.za, Lamprecht, Sandra C.¹, Vaughan, Martha M.², Doehring, Gail², O'Donnell, Kerry²

المصدر: Plant Disease. Jan2017, Vol. 101 Issue 1, p150-157. 8p.

مصطلحات موضوعية: *SOYBEAN sudden death syndrome, *SOYBEAN diseases & pests, *FUSARIUM, *ELONGATION factors (Biochemistry), *SOYBEAN varieties

المؤلفون: Lestari, Puji¹ plestari129@yahoo.com, Suli Sun², Hokyeong Son³, Yin-Won Lee³, Suk-Ha Lee⁴

المصدر: Journal of Microbiology, Biotechnology & Food Sciences. Dec2016/Jan2017, Vol. 6 Issue 3, p950-955. 6p.

مصطلحات موضوعية: *SOYBEAN sudden death syndrome, *FUSARIUM solani, *FUNGI classification, *FUNGAL morphology

مصطلحات جغرافية: KOREA

المؤلفون: Marburger, David A.¹ dmarburger@wisc.edu, Smith, Damon L.², Conley, Shawn P.³

المصدر: Plant Disease. Oct2016, Vol. 100 Issue 10, p2152-2157. 6p.

مصطلحات موضوعية: *SOYBEAN sudden death syndrome, *SOYBEAN disease & pest prevention, *PLANT diseases, *CONTROL of phytopathogenic microorganisms, *SOYBEAN yield

المؤلفون: Vrtikapa, Dejan, Krasowski, Ashley A, Orland, Kate M, Eckhardt, Lee L

المصدر: HeartRhythm Case Rep ; ISSN:2214-0271 ; Volume:10 ; Issue:11

مصطلحات موضوعية: Brugada syndrome, arrhythmia risk, sex differences, sudden death syndrome

Relation: https://doi.org/10.1016/j.hrcr.2024.08.010; https://pubmed.ncbi.nlm.nih.gov/39664676; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11628791/

الاتاحة: https://doi.org/10.1016/j.hrcr.2024.08.010
https://pubmed.ncbi.nlm.nih.gov/39664676
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11628791/

المؤلفون: Ernat, Edward

المساهمون: Mueller, Daren S., Leandro, Leonor F. S., Archontoulis, Sotirios V., Plant Pathology

مصطلحات موضوعية: Plant pathology, environment, evaluation, risk, seed treatment, soybean, Sudden death syndrome

وصف الملف: PDF; application/pdf

Relation: https://dr.lib.iastate.edu/handle/20.500.12876/8zn7DNPw

الاتاحة: https://dr.lib.iastate.edu/handle/20.500.12876/8zn7DNPw
https://hdl.handle.net/20.500.12876/8zn7DNPw

المؤلفون: Crous, P.W., Lombard, L., Sandoval-Denis, M., Seifert, K.A., Schroers, H.-J., Chaverri, P., Gené, J., Guarro, J., Hirooka, Y., Bensch, K., Kema, G.H.J., Lamprecht, S.C., Cai, L., Rossman, A.Y., Stadler, M., Summerbell, R.C., Taylor, J.W., Ploch, S., Visagie, C.M., Yilmaz, N., Frisvad, J.C., Abdel-Azeem, A.M., Abdollahzadeh, J., Abdolrasouli, A., Akulov, A., Alberts, J.F., Araújo, J.P.M., Ariyawansa, H.A., Bakhshi, M., Bendiksby, M., Ben Hadj Amor, A., Bezerra, J.D.P., Boekhout, T., Câmara, M.P.S., Carbia, M., Cardinali, G., Castañeda-Ruiz, R.F., Celis, A., Chaturvedi, V., Collemare, J., Croll, D., Damm, U., Decock, C.A., de Vries, R.P., Ezekiel, C.N., Fan, X.L., Fernández, N.B., Gaya, E., González, C.D., Gramaje, D., Groenewald, J.Z., Grube, M., Guevara-Suarez, M., Gupta, V.K., Guarnaccia, V., Haddaji, A., Hagen, F., Haelewaters, Danny, Hansen, K., Hashimoto, A., Hernández-Restrepo, M., Houbraken, J., Hubka, V., Hyde, K.D., Iturriaga, T., Jeewon, R., Johnston, P.R., Jurjević, Ž., Karalti, İ., Korsten, L., Kuramae, E.E., Kušan, I., Labuda, R., Lawrence, D.P., Lee, H.B., Lechat, C., Li, H.Y., Litovka, Y.A., Maharachchikumbura, S.S.N., Marin-Felix, Y., Matio Kemkuignou, B., Matočec, N., McTaggart, A.R., Mlčoch, P., Mugnai, L., Nakashima, C., Nilsson, R.H., Noumeur, S.R., Pavlov, I.N., Peralta, M.P., Phillips, A.J.L., Pitt, J.I., Polizzi, G., Quaedvlieg, W., Rajeshkumar, K.C., Restrepo, S., Rhaiem, A., Robert, J., Robert, V., Rodrigues, A.M., Salgado-Salazar, C., Samson, R.A., Santos, A.C.S., Shivas, R.G., Souza-Motta, C.M., Sun, G.Y., Swart, W.J., Szoke, S., Tan, Y.P., Taylor, J.E., Taylor, P.W.J., Tiago, P.V., Váczy, K.Z., van de Wiele, N., van der Merwe, N.A., Verkley, G.J.M., Vieira, W.A.S., Vizzini, A., Weir, B.S., Wijayawardene, N.N., Xia, J.W., Yáñez-Morales, M.J., Yurkov, A., Zamora, J.C., Zare, R., Zhang, C.L., Thines, M.

المصدر: STUDIES IN MYCOLOGY ; ISSN: 0166-0616 ; ISSN: 1872-9797

مصطلحات موضوعية: Biology and Life Sciences, multi-gene phylogeny, mycotoxins, Nectriaceae, Neocosmospora, novel taxa, pathogen, taxonomy, FUJIKUROI SPECIES COMPLEX, DESORPTION IONIZATION-TIME, FLIGHT MASS-SPECTROMETRY, DELPHINOIDES STRAIN GPK, SUDDEN-DEATH SYNDROME, HEAD BLIGHT PATHOGEN, SP-NOV, FUNGUS FUSARIUM, NECTRIACEAE HYPOCREALES, STRUCTURE ELUCIDATION

وصف الملف: application/pdf

Relation: https://biblio.ugent.be/publication/8733875; http://hdl.handle.net/1854/LU-8733875; http://dx.doi.org/10.1016/j.simyco.2021.100116; https://biblio.ugent.be/publication/8733875/file/8733876

الاتاحة: https://biblio.ugent.be/publication/8733875
http://hdl.handle.net/1854/LU-8733875
https://doi.org/10.1016/j.simyco.2021.100116
https://biblio.ugent.be/publication/8733875/file/8733876

المؤلفون: Aisha A. Alblooshi, Gouthaman P. Purayil, Esam Eldin Saeed, Gaber A. Ramadan, Saeed Tariq, Amna S. Altaee, Khaled A. El-Tarabily, Synan F. AbuQamar

المصدر: Journal of Fungi; Volume 8; Issue 1; Pages: 8

مصطلحات موضوعية: biocontrol, date palm, endophytic actinobacteria, Fusarium solani, sudden death syndrome, Streptomyces

جغرافية الموضوع: agris

وصف الملف: application/pdf

Relation: Environmental and Ecological Interactions of Fungi; https://dx.doi.org/10.3390/jof8010008

الاتاحة: https://doi.org/10.3390/jof8010008

المؤلفون: Costa, Sarah S.¹, Matos, Kedma S.¹, Tessmann, Dauri J.², Seixas, Claudine D.S.³, Pfenning, Ludwig H.¹ ludwig@dfp.ufla.br

المصدر: Fungal Biology. Jan2016, Vol. 120 Issue 1, p51-60. 10p.

مصطلحات موضوعية: *SOYBEAN sudden death syndrome, *SOYBEAN diseases & pests, *ROOT rots, *FUSARIUM diseases of plants, *NUCLEOTIDE sequence

مصطلحات جغرافية: BRAZIL

المؤلفون: Jie Wang¹, Jacobs, Janette L.¹, Byrne, Jan M.¹, Chilvers, Martin I.¹ chilvers@msu.edu

المصدر: Phytopathology. Mar2015, Vol. 105 Issue 3, p378-387. 10p.

مصطلحات موضوعية: *FUSARIUM diseases of plants, *SOYBEAN sudden death syndrome, *SOYBEAN diseases & pests, *POLYMERASE chain reaction, *RIBOSOMAL DNA

المؤلفون: Boucher, Kelsey

المساهمون: Rajcan, Istvan, Eskandari, Milad

مصطلحات موضوعية: Ontario soybeans, Sudden Death Syndrome, GWAS, Disease resistance

وصف الملف: application/pdf

Relation: https://hdl.handle.net/10214/28694

الاتاحة: https://hdl.handle.net/10214/28694